Early staging and treatment initiation affect prognosis of patients with esophageal and esophagogastric junction cancer; hence, it is imperative to have knowledge of proper choice of imaging modality for staging of these patients, to effectively convey relevant imaging findings to the treating physician/surgeon. It is also essential to be aware of pertinent imaging findings that need to be conveyed to the treating physician/surgeon at staging, and after treatment, including post-therapy complications (if any), so as to provide timely management to such patients. In this article, we have provided imaging guidelines for diagnosis, staging, post-therapy response evaluation, follow-up, and assessment of post-therapy complications of esophageal and esophagogastric junction cancer in a systematic manner. Besides, risk factors and clinical workup have also been elucidated. We have also attached comprehensive staging and post-therapy contrast-enhanced computed tomography and fluorodeoxyglucose-positron emission tomography/computed tomography-based synoptic reporting formats “ECI-RADS” and “pECI-RADS,” respectively, for esophageal and esophagogastric junction cancer in the supplement, for effective communication of imaging findings between a radiologist and the treating physician/surgeon.

Ganglioneuroblastoma is an uncommon peripheral neuroblastic tumor. They have intermediate malignant potential, in between that of neuroblastomas and ganglioneuromas. Histologically, they are considered to have intermediate malignant potential because they contain primitive neuroblasts along with mature ganglion cells. In literature, reports of this entity being diagnosed by fine needle aspiration and its cytological appearance are scarce.

BACKGROUND: Uterine lipoleiomyoma is uncommon and rare entity. Although presumed to be benign, it has been inadequately studied. Adipose tissue is infrequently found within uterine leiomyoma with unknown histogenesis, thus it is unusual and rare finding in routine histopathology practice. AIM: The observation of a case of lipoleiomyoma stimulated us to ascertain the real incidence of this lesion which is commonly considered to be rare. CASE SUMMARY: 36 year old female presented with mass per abdomen associated abnormal uterine bleeding since 3 months. She underwent hysterectomy without any complication. Grossly, uterus was enlarged and cut surface revealed well circumscribed grey white mass measuring around 5x3x2 cms with yellowish area. Section showed features of adipose tissue embedded within leiomyoma. DISCUSSION: The presence of fatty tissue in the myometrium is anomalous; this alteration has been interpreted either as a lipomatous degeneration or as a metaplasia of smooth muscle cells or, still, as a real neoplasm, frequently associated with a leiomyoma, the socalled lipoleiomyoma. CONCLUSION: lipoleiomyoma of the uterus is very rare benign tumor with unknown histogenesis and only few cases have been reported so far, thus it prompts us to present.

Solid-pseudopapillary tumors are unusual pancreatic neoplasms of low malignant potential that most frequently affect young women. They are histologically, clinically, and prognostically quite distinct from the more common pancreatic ductal adenocarcinomas. Despite their often large size the vast majority of solid-pseudopapillary tumors are indolent neoplasms. They are confined to the pancreas in 85% of patients, and even the 10 to 15% of patients with liver or peritoneal metastases commonly enjoy long-term survival.